These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8468110)

  • 1. The antimicrobial actions of taurolin and other preparations on the pathogenic spectrum in dentoalveolar infections.
    Zimmermann M; Preac-Mursic V
    Int J Clin Pharmacol Ther Toxicol; 1993 Mar; 31(3):130-6. PubMed ID: 8468110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of taurolidine, chlorophenol-camphor-menthol and chlorhexidine against oral pathogenic microorganisms.
    Zimmermann M; Preac-Mursic V
    Arzneimittelforschung; 1992 Sep; 42(9):1157-9. PubMed ID: 1445486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taurolin as an oral rinse. I. Antimicrobial effects in vitro and in vivo.
    Reynolds S; Moran J; Addy M; Wade WG; Newcombe R
    Clin Prev Dent; 1991; 13(2):13-7. PubMed ID: 1860285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taurolin as an oral rinse. II. Effects on in vitro and in vivo plaque regrowth.
    Reynolds S; Moran J; Wade WG; Addy M; Newcombe R
    Clin Prev Dent; 1991; 13(2):18-22. PubMed ID: 1860286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial therapy of purulent peritonitis: a prospective randomized study on the effects of antibiotics and taurolin, a new chemotherapeutic and antiendotoxic agent (author's transl)].
    Linder MM; Ott W; Wesch G
    Chir Forum Exp Klin Forsch; 1980; ():67-71. PubMed ID: 7389482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection].
    Weber M; Meyer F; Halloul Z
    Zentralbl Chir; 2009 Aug; 134(4):350-6. PubMed ID: 19688684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal absorption of the antibacterial and antiendotoxin taurolin in peritonitis.
    Knight BI; Skellern GG; Browne MK; Pfirrmann RW
    Br J Clin Pharmacol; 1981 Nov; 12(5):695-9. PubMed ID: 7332737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of antimicrobial action of polyhexametylenguanide hydrochloride (Biopag) and chlorhexidine bigluconate upon potential infectious agent of suppurative-inflammatory diseases of maxillo-facial region and neck].
    Shipskiĭ AV; Afanas'ev VV; Polikarpov NA; Efimov KM; Dmitruk IB
    Stomatologiia (Mosk); 2007; 86(3):46-50. PubMed ID: 17690643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rate of antimicrobial action of noxythiolin and taurolin.
    Brearley S; George RH
    J Hosp Infect; 1980 Sep; 1(3):201-9. PubMed ID: 6182213
    [No Abstract]   [Full Text] [Related]  

  • 10. Cooperativity between antibiotics and antiseptics: testing the bactericidal effect.
    Jenull S; Laggner H; Hassl I; Velimirov B; Huettinger M; Zemann N
    J Wound Care; 2017 Dec; 26(12):720-726. PubMed ID: 29244973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro and in vivo activity of taurolin against anaerobic pathogenic organisms.
    Browne MK; Leslie GB; Pfirrman RW; Brodhage H
    Surg Gynecol Obstet; 1977 Dec; 145(6):842-6. PubMed ID: 201040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the microbial antiadherence capacities of three antimicrobial agents.
    Gorman SP; McCafferty DF; Woolfson AD; Jones DS
    J Clin Pharm Ther; 1987 Dec; 12(6):393-9. PubMed ID: 3326886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of peritonitis. 6-year experience with the chemotherapeutic agent and anti-endotoxin taurolin].
    Wesch G; Petermann C; Linder MM
    Fortschr Med; 1983 Mar; 101(12):545-50. PubMed ID: 6343207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The therapy of the postextraction syndrome with Taurolin. A controlled clinical study].
    Zimmermann M; Nentwig GH
    Schweiz Monatsschr Zahnmed; 1992; 102(11):1327-32. PubMed ID: 1470889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
    Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
    J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of bacterial pathogens against lincomycin/spectinomycin (1/2), penicillin G/neomycin (1/1), and penicillin G/dihydrostreptomycin (1/1) as determined in the BfT-GermVet monitoring program 2004-2006.
    Schwarz S; Werckenthin C; Alesík E; Wieler LH; Wallmann J
    Berl Munch Tierarztl Wochenschr; 2007; 120(9-10):363-71. PubMed ID: 17939451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.
    Jones RN; Li Q; Kohut B; Biedenbach DJ; Bell J; Turnidge JD
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):63-71. PubMed ID: 16368476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agent.
    Gorman SP; McCafferty DF; Woolfson AD; Jones DS
    J Appl Bacteriol; 1987 Apr; 62(4):315-20. PubMed ID: 3298185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mode of antibacterial action of some 'masked' formaldehyde compounds.
    Gidley MJ; Sanders JK; Myers ER; Allwood MC
    FEBS Lett; 1981 May; 127(2):225-7. PubMed ID: 7016592
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-adherence properties of taurolidine and noxythiolin.
    Blenkharn JI
    J Chemother; 1989 Jul; 1(4 Suppl):233-4. PubMed ID: 16312382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.